NGS

  • Placeholder

    Comprehensive NGS Colorectal Cancer Panel Test – Accurate Genetic Screening

    4.000,00 د.إ

    NGS Colorectal Cancer Panel Test – Comprehensive Genetic Profiling for Precision Oncology The NGS Colorectal Cancer Panel Test from Lab Tests Dubai is a cutting-edge, next-generation sequencing (NGS) diagnostic tool that analyzes the genetic makeup of colorectal tumors to guide precision treatment, predict drug response, and identify hereditary cancer syndromes like Lynch syndrome. This advanced…

  • Placeholder

    Mitochondrial DNA Sequencing | High-Accuracy mtDNA Analysis for Research & Medicine

    3.750,00 د.إ

    Mitochondrial DNA (mtDNA) Sequencing provides high-resolution analysis of mitochondrial genomes, enabling precise identification of genetic variations. Key features include full-length mtDNA sequencing, high accuracy, and deep coverage, ensuring reliable detection of mutations and heteroplasmy. Benefits include applications in ancestry research, forensic identification, disease association studies, and evolutionary biology.

  • Placeholder

    Oncomine Acute Myeloid Leukemia (AML) Panel – Targeted NGS Solution for AML Research

    5.500,00 د.إ

    The Oncomine Acute Myeloid Leukaemia (AML) Panel is a targeted next-generation sequencing (NGS) assay designed for comprehensive genomic profiling of AML. It enables simultaneous detection of key mutations, gene fusions, and copy number variations across clinically relevant genes associated with AML.

  • Placeholder

    Oncomine Myeloproliferative Neoplasm (MPN) Panel – Accurate NGS Testing for MPN Mutations

    5.500,00 د.إ

    The Oncomine Myeloproliferative Neoplasm (MPN) Panel is a targeted next-generation sequencing (NGS) assay designed for the comprehensive detection of key driver mutations in myeloproliferative neoplasms. It enables the simultaneous analysis of JAK2, CALR, and MPL genes, which are critical for MPN diagnosis and classification. The panel offers high sensitivity, detecting low-frequency variants with as little as 10 ng of input RNA or DNA, making it ideal for limited or degraded samples.

  • Placeholder

    Whole Exome Sequencing

    5.375,00 د.إ

    Whole Exome Sequencing (WES) is a powerful genetic testing method that sequences all protein-coding regions (exons) of the genome, covering approximately 1-2% of the DNA where most disease-causing mutations occur. It offers a cost-effective alternative to whole genome sequencing while providing high-depth coverage for accurate variant detection. WES enables the identification of genetic mutations linked to inherited disorders, cancer, and rare diseases, making it a valuable tool for clinical diagnostics, personalized medicine, and research.

WhatsApp Call